Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Durango $DGO.ca $ATOXF Applies for Discovery Property Drill Permits in Frotet Evans Greenstone Belt $TRG.ca $KLD.ca $OSK.ca

Posted by AGORACOM at 9:40 AM on Wednesday, April 21st, 2021

Durango Resources Inc. (TSXV:DGO) (Frankfurt-86A1) (OTC:ATOXF), (the “Company” or “Durango”) reports that further to the news of April 1, 2021, Durango has applied for drill permits on its wholly owned Discovery property.

Durango’s Discovery (Découverte) Property is located on strike to the southwest of the past producing Troilus gold mine owned by Troilus Gold Corp. (“Troilus”) (TSX-TLG) and neighbours UrbanGold Minerals Inc. (TSXV-UGM). https://www.durangoresourcesinc.com/_resources/images/Discovery-Property-April-2021.jpg  

The Discovery Property is 6,700ha in size and covers an important geological NE-SW regional structure which continues towards Troilus. The Property has great road access from the Route du Nord and is easily accessible due to the unusually warm spring weather conditions. Durango has applied for 15 exploration drill holes on the Discovery property for the 2021 exploration season.

Durango’s technical team is in the process of preparing an exploration program for the Discovery Property in June 2021, after it completes its exploration program at Windfall Lake and will announce the plans in more detail as they become available.

Durango CEO, Marcy Kiesman, stated, “Durango’s previous grab samples returned up to 7 g/t gold at surface on the Discovery property in a quartz vein in basalt. We look forward to receiving our permits so we can conduct follow up work on the Discovery property this summer.”

The technical contents of this press release were approved by George Yordanov, professional geologist, an Independent Qualified Person as defined by National Instrument 43-101. The Discovery Property has not yet been subject to an NI-43-101 report.

Discovery (Découverte), Québec

Durango owns 100% interest in the Discovery claims, which are adjacent Osisko Mining Inc. (TSX-OSK) and are 60km away from Troilus Gold Inc.’s past producing mine. The claims are located 100km away from Chibougamau, Québec in the Frotet Evans greenstone belt with year-round road access from the Route Nord. The 6,700-hectare property is compelling due to the structurally important south dipping synclinal fold nose deformed by a northwest fault zone and northeast structures.

Read More: https://agoracom.com/ir/Durango/forums/discussion/topics/759440-durango-applies-for-discovery-property-drill-permits-in-frotet-evans-greenstone-belt/messages/2312844#message

Red Light Holland $TRIP.ca $TRUFF Increases Points of Sale for iMicrodose Packs in the Netherlands by More Than 140% $RVV.ca $PSYC $FTRP $BUZZ

Posted by AGORACOM at 9:17 AM on Wednesday, April 21st, 2021
Corporate Logo

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to provide an update on the distribution of its iMicrodose Packs in the Netherlands.

“Over the last few months, we have continued executing on our goal to increase both the availability of our products and our brand’s visibility. iMicrodose Packs powered by Red Light Holland are now available in 144% more locations than previously announced. Relationships held by our wholly owned distribution company SR Wholesale, already, account for 13 new locations, demonstrating some of the synergies that we strategically planned to realize from the recently closed acquisition,” said Todd Shapiro, CEO and Director of Red Light Holland. “With over $31 million of cash and cash equivalents remaining on our balance sheet, we look forward to continuing to conservatively deploy capital into growth opportunities that support our long-term business objectives, while SR-Wholesale continues to do a major sales push across the Netherlands. We have a clear plan to get Red Light Holland products into many more retail stores hopefully for the summer market, while also concentrating on growing our online sales at www.iMicrodose.nl. As I’ve said in the past, we’re proud to be providing access now and we continue to deliver on that mandate.”

About Red Light Holland Corp.

The Company is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

American Creek $AMK.ca: Brookville Capital Covers Treaty Creek Partners $TUD.ca $SEA.ca $ESK.ca

Posted by AGORACOM at 9:11 AM on Wednesday, April 21st, 2021
American Creek Provides Update on Its First Quarter Filings

Brookville Capital Intelligence Report Covers Treaty Creek Partners 

The Brookville Capital Intelligence Report is a weekly newsletter out of London that covers the commodities markets.    It tells subscribers about a wide variety of companies and has delivered some very strong returns. For example it told subscribers about Chalice when it was 15.5 cents and today it’s over $6.   

More information can be found at www.Brookvillecapital.com

CLICK TO VIEW

MORE COVERAGE:

Commodity TV is a channel focused on mining companies, experts, analysts and professional opinions of funds managers and more. Their video presentation of Treaty Creek can be found by clicking through the button below.  

LINK TO COMMODITY TV PRESENTATION

EVEN MORE COVERAGE:

Fundamental Research Corp is one of the largest independent research houses in the world, with a 17-year track record of covering 550+ companies. As of April 05, 2021, FRC’s top picks were up 69.3% on average since initiation of coverage. Last week they initiated coverage on our JV Partner Tudor Gold / Treaty Creek.

The comprehensive report mention on Commodity TV can be accessed on their website by subscribing to their free membership.

LINK TO EVEN MORE COVERAGE

EVEN, EVEN MORE COVERAGE:
Stansberry Research, one of the largest investment research firms in the United States, had initiated coverage of Tudor Gold  / Treaty Creek last year and issued an update on April 7th, 2021.  This article can be accessed by subscribing to the Gold & Silver Report at Stansberry Research.  

LINK TO STANSBERRY GOLD AND SILVER RESEARCH

  You can find us on twitter and Linked In 

Find out more at www.americancreek.com

XPhyto Therapeutics $XPHY.ca $XPHYF Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:21 AM on Wednesday, April 21st, 2021
http://blog.agoracom.com/wp-content/uploads/2021/01/XPHYTO-70-x-70.jpg

XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it has entered into an agreement (the “Agreement”) with an established German pharmaceutical wholesaler and service provider (the “Distributor”) for the distribution, storage and logistics of XPhyto’s diagnostic products in Germany. The Agreement secures XPhyto a full-service distribution partner for its 25-minute SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab is registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.

Pursuant to the Agreement, the Distributor will distribute, store and deliver Covid-ID Lab test kits according to the product specifications and all applicable regulations to XPhyto’s customers. In addition, the Distributor will provide the documentation and fulfillment of storage obligations, the fulfillment of reporting and notification obligations, and the processing of any returned products. The obligations and services to be rendered under the Agreement satisfy all of the logistical and regulatory requirements for the commercial sale of COVID-ID Lab in Germany.

“With this agreement, we have secured a strong partner with an established medical distribution network throughout Germany. This is an exciting and critical step towards commercial sales of COVID-ID Lab,” said Hugh Rogers, CEO and Director of XPhyto. “The Company’s commercialization strategy is focused on the German market for initial product launch and the creation of robust and sustainable sales.”

Covid-ID Lab is a multiplex viral RNA probe kit based on the reverse transcriptase-polymerase chain reaction (RT-PCR) method. Covid-ID Lab requires only a single 20-minute PCR thermal cycle for assay performance without prior RNA extraction as part of the sample preparation. Many widely available standard PCR instruments are suitable to run the test. Results are collected after the PCR cycle via easy-to-read optical indicator strips on a simple fluidics platform. The elimination of RNA extraction for sample preparation reduces cross-contamination risk and minimizes the need for lab materials and trained personnel. The rapid results, minimal laboratory equipment, and ease of use are expected to translate into reduced operating costs, greater convenience and portability.

XPhyto is currently in discussions with various potential customers, distribution and wholesale partners as well as potential licensees. The sales launch in Europe is targeted for April 2021. The Company will provide further information and updates in due course.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic.

About XPhyto Therapeutics Corp.

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

Read More:https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/759431-xphyto-signs-german-distribution-storage-and-logistics-agreement-for-25-minute-covid-19-pcr-test/messages/2312832#message

KWESST $KWE.ca $KWEMF Announces U.S. Patent Award for Phantom(TM), Qualifies for Government Programs $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 3:07 PM on Tuesday, April 20th, 2021

Electronic decoy product advances to sponsorship and evaluation with U.S. military and another NATO nation

  • Announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy
  • This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020

Ottawa, Ontario–(April 20, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy. This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020.

In conjunction with the patent award, the Company confirmed that the PhantomTM system has just been selected in defence and innovation programs for evaluation, including a U.S. Special Operations Command program, and has been prequalified for government funding with an estimated initial value of approximately $1 million once approved.

“Apart from the potential near-term dollars involved, this qualification and invitation to participate in trials with key agencies in the U.S. and another NATO country signals serious interest in the PhantomTM system,” said Jeff MacLeod, KWESST Founder, President and CEO. He adds that, “These concurrent developments also appear likely to accelerate the pace of market uptake. Accordingly, with the upcoming close of our $4 million financing announced April 9, 2021 we will be prioritizing the productization of PhantomTM to be in the market sooner than originally planned.”

The Company stated that there is growing interest among NATO and partner countries for a tactical electronic decoy to prevent adversaries from locating and targeting friendly forces. This growing interest stems from incidents like one publicly reported in the 2016 where two full Ukrainian mechanized battalions were annihilated by Russian adversaries in three minutes with precision mass fire after locating them based on their electronic signal emissions.

About the PhantomTM electronic decoy
PhantomTM is a compact, lightweight electromagnetic transmitter capable of mimicking the electromagnetic signature of a tactical military unit, fooling adversaries as to the location of NATO and partner nation forces. Recent interest from NATO agencies and defence contractors for this product has resulted in KWESST moving up the scheduled production of demonstration samples of PhantomTM in the Company’s priorities. An earlier prototype version of PhantomTM was procured and successfully trialed in military exercises. The latest version is more compact, with greater capability, and is soldier-portable or can be deployed by Unmanned Aerial Systems (“UAVs” or “drones”). Based on internal research the Company estimates the market for a system like PhantomTM to be worth several hundred million dollars in the U.S. alone.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/759400-kwesst-announces-u-s-patent-award-for-phantom-tm-qualifies-for-government-programs/messages/2312755#message

Mountain Valley MD $MVMD $MVMDF Holdings Inc. Proceeding with Application to List on the TSX Venture Exchange $CTLT $MRNA $NVAX

Posted by AGORACOM at 8:47 AM on Tuesday, April 20th, 2021

Mountain Valley MD Holdings Inc. (the “Company” or “MVMD“) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce that it is proceeding with the application for the listing of its shares for trading on the TSX Venture Exchange (“TSXV”).  The Company’s board of directors has approved the move and the Company intends to submit an application to the TSXV this week.

“We believe that pursuing a listing on the TSX-V is a great step for Mountain Valley MD Holdings Inc. and will provide increased liquidity and trading capabilities in MVMD’s common shares for both institutional and retail investors,” stated Dennis Hancock, President and CEO of Mountain Valley MD.  “This is a significant part of our efforts to broaden our appeal to a larger shareholder base and continue to raise the Company’s profile among the North American investment community.”

Completion of the listing on the TSXV is subject to the satisfaction of listing requirements and the approval of the TSXV.  In the meantime, MVMD’s shares will continue to trade on the Canadian Securities Exchange under the ticker symbol “MVMD”.  Further updates will be provided as they become available.

ABOUT MOUNTAIN VALLEY MD HOLDINGS INC
Mountain Valley MD is building a world-class biotech and life sciences company organization centred around the implementation of its patented Quicksome™ oral drug formulation and delivery technologies and its Quicksol™ solubilization technology for macrocyclic lactones, to innovate industry leading products that are sought out globally.

MVMD’s proposition for delivering Quicksome™ formulations that have rapid onset, high bioavailability, low variability and precision dosing is core to the Company’s success across key health and wellness categories. Consistent with its vision towards “Helping People Live Their Best Life”, MVMD applies its Quicksome™ and Quicksol™ technologies to its ground-breaking work for advanced delivery of vaccines and pharmaceutical drugs as well as the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more.

The Company’s patented Quicksome™ desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats that are consumed orally.  The result is a new generation of product formulations that are capable of delivering vaccines, drugs and nutraceuticals into the body faster, with greater impact, efficiency and accuracy. 

Read More: https://agoracom.com/ir/MountainValleyMD/forums/discussion/topics/759352-mountain-valley-md-holdings-inc-proceeding-with-application-to-list-on-the-tsx-venture-exchange/messages/2312668#message

XPhyto Therapeutics $XPHY.ca $XPHYF Adds Top-Level Executive Talent to its Global Operations $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 8:12 AM on Tuesday, April 20th, 2021
http://blog.agoracom.com/wp-content/uploads/2021/01/XPHYTO-70-x-70.jpg
  • Mr. Wolfgang Probst appointed as the Chief Operations Officer (COO) of XPhyto
  • Addition of Mr. Manfred Buchberger as the Head of Corporate Development

XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as the Head of Corporate Development at XP Diagnostics GmbH (“XP Diagnostics”), a wholly owned German subsidiary of the Company. With European CE-IVD approval announced March 18, 2021, for the Company’s lead diagnostic product, Covid-ID Lab, XPhyto continues to enhance its commercial team as it anticipates near-term distribution and sales.

Mr. Probst is an experienced management and finance consultant with expertise in mergers and acquisitions, corporate re-organizations, and divestitures. He has a proven track record of leadership, strategic planning, and organizational restructuring having guided multiple startups from inception to financial success. Mr. Probst was responsible for successfully structuring XPhyto’s European operations and establishing associated partnerships and collaborations, both commercial and academic. As the newly appointed COO of XPhyto, Mr. Probst will be responsible for managing the Company’s global operations. Mr. Probst will remain a director of XPhyto and the managing director of XP Diagnostics.

Mr. Buchberger is a global leader in the medical diagnostics industry. For almost a decade, he was the CEO and a member of the Global Management Board of a major European medical diagnostics and analytics company with annual revenues of over 600 million Euro. His addition to the Company brings decades of diagnostics industry experience focused on international business development, sales, marketing, and product management. Mr. Buchberger has successfully created, implemented, and managed business growth strategies across Europe, North and South America, Middle East and Asia, including the successful launch of new medical diagnostic products.

On March 18, 2021, XPhyto announced European commercial approval of Covid-ID Lab, a rapid 25-minute point-of-care PCR test for COVID-19. Mr. Probst and Mr. Buchberger will be responsible for executing the global product launch and businesses development of Covid-ID Lab.

Covid-ID Lab is a multiplex viral RNA probe kit based on the reverse transcriptase-polymerase chain reaction (RT-PCR) method. Covid-ID Lab requires only a single 20-minute PCR thermal cycle for assay performance without prior RNA extraction as part of the sample preparation. Many widely available standard PCR instruments are suitable to run the test. Results are collected after the PCR cycle via easy-to-read optical indicator strips on a simple fluidics platform. The elimination of RNA extraction for sample preparation reduces cross-contamination risk and minimizes the need for lab materials and trained personnel. The rapid results, minimal laboratory equipment, and ease of use are expected to translate into reduced operating costs, greater convenience and portability.

Read More: https://agoracom.com/ir/XphytoTherapeutics/forums/discussion/topics/759347-xphyto-adds-top-level-executive-talent-to-its-global-operations/messages/2312660#message

Candente Copper $DNT.ca Provides Update for Ausenco Conceptual Desk Top Study on Cañariaco Norte $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM at 8:27 AM on Monday, April 19th, 2021
  • Ausenco Update for Conceptual Desk Top Study on Cañariaco Norte

Candente Copper Corp. (TSX:DNT, BVL:DNT) (“Candente Copper”, “Company”) is pleased to announce that the Desk Top Conceptual Study (“Study”) that is being conducted by Ausenco is advancing well. The mandate of the study is to identify opportunities for Cañariaco Norte to be built as a smaller higher grade project with a lower initial capital expenditure (“CapEx”) and accelerated payback period.

In addition to seeking a higher copper grade for the starter pit, we are investigating other opportunities to lower the CapEx and operational expenditures (“OpEx”) and consider better environmental, social and governance (“ESG”) practices.  All of the Desk Top work considers the potential for expansion into a larger project over time.

“While the work has taken up more time than we initially anticipated, the opportunities already identified by Ausenco to improve the project are well worth the wait.” says Joanne Freeze, President and CEO. “A more comprehensive Desk Top Study will allow the Company to follow it with a preliminary economic assessment (“PEA”) on the best possible project and we are already seeing detailed optimizations that should make substantial improvements to the project”.

Work to date has focused on:

  1. Geometallurgical modelling which identifies both a wider range of metal contents in the different rock types and a wider range of metal recoveries to concentrate from the various rock types.  Combining these two aspects allows the forecast of concentrate quality followed by production that offers more flexibility and the ability to plan mine scheduling to optimize project value.  
  2. The identification of current markets for our unique copper concentrate which indicate higher potential revenues due to a decrease in treatment costs.

For more details about the Study, please see News Release No. 127 (dated February 25th, 2021): https://www.candentecopper.com/news-releases/news-releases/2021/ausenco-engaged-for-desk-top-studies-on-canariaco-norte-higher-grade-project.

Read More: https://agoracom.com/ir/CandenteCopper/forums/discussion/topics/759279-candente-copper-provides-update-for-ausenco-conceptual-desk-top-study-on-ca-ariaco-norte/messages/2312533#message

Blockchain Foundry $BCFN.ca Expands Leadership Team with Key Management Hires $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 8:19 AM on Monday, April 19th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/10/blockchain-foundry-square.png
  • Announced that it has expanded its leadership team with two key management hires who joined the Company today
  • Fulvio Ciano is joining the Company as Director of Software Development Consulting & Delivery and will be responsible for all aspects of BCF’s consulting practice and associated software delivery.
  • Mr. Ciano is a seasoned software executive with decades of experience managing delivery teams
  • Peter Jubb is joining the Company as Executive Creative Director and will be responsible for all aspects of BCF’s product design, branding, and creative content

TORONTO, April 19, 2021 — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that it has expanded its leadership team with two key management hires who joined the Company today.

Fulvio Ciano is joining the Company as Director of Software Development Consulting & Delivery and will be responsible for all aspects of BCF’s consulting practice and associated software delivery. Mr. Ciano is a seasoned software executive with decades of experience managing delivery teams.

Peter Jubb is joining the Company as Executive Creative Director and will be responsible for all aspects of BCF’s product design, branding, and creative content. Mr. Jubb has over 20 years’ experience as a creative director and information architect and brings a wealth of practical experience to the team.

Mr. Ciano and Mr. Jubb will both join the Company’s executive committee and will have direct input into BCF’s strategy going forward.

“We are excited to welcome Fulvio and Peter to the BCF team, and we look forward to their contributions as we continue to grow the business,” said Dan Wasyluk, CEO of BCF. “We are in the process of expanding into new product areas while continuing to grow our established consulting business, and these new additions to the team will dramatically accelerate our growth trajectory.”

About Blockchain Foundry Inc.

Blockchain Foundry develops and commercializes blockchain-based business solutions and provides consulting services to corporate clients seeking to incorporate blockchain technology into their businesses.

Blockchain Foundry Contact Information:

Chris Marsh
President
[email protected]
(647) 330-4572

Forward-Looking Information

Certain portions of this press release contain “forward-looking information” within the meaning of applicable Canadian securities legislation, which is also referred to as “forward-looking statements”, which may not be based on historical fact. Wherever possible, words such as “will”, “plans,” “expects,” “targets,” “continues”, “estimates,” “scheduled,” “anticipates,” “believes,” “intends,” “may,” “could,” “would” or might, and the negative of such expressions or statements that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken, occur or be achieved, have been used to identify forward-looking information.

Forward-looking statements should not be read as guarantees of future events, future performance or results, and will not necessarily be accurate indicators of the times at, or by which, such events, performance or results will be achieved, if achieved at all. Readers should not place undue reliance on such forward-looking statements, as they reflect management’s current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BCF are inherently subject to significant business, economic, regulatory, competitive, political and social uncertainties, and contingencies. Many factors could cause BCF’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

SX Eco-Mining $SX.ca $SXOOF Secures Future EV Batteries Recycling Plant & Engineering $NNX.ca $OM.ca $ICM.ca $ATAO

Posted by AGORACOM at 8:17 AM on Monday, April 19th, 2021

St-Georges Eco-Mining Corp. (CNSX:SX.CN)(OTC:SXOOF) (FSE:85G1) is pleased to disclose that it has entered a binding term sheet to secure the site and building for its proposed battery recycling plant in the deep seaport of Baie-Comeau on the Québec North Shore.

The parties will have 30 days to finalize and execute a long-form agreement conditional on the positive outcome of the feasibility study already underway. Part of the binding agreement concerns the access to the engineering expertise that will allow the Company to have trained professionals working in the facilities from day one of operations planned for later this year.

Important milestone reached allowing equipment vendors to share information with the newly secured engineering team to accelerate the design of the Baie-Comeau proposed electric vehicle, or EV, battery recycling plant with a target phase 1 production capability of 10,000 annual metric tonnes.

The agreement, a long-term lease with an option to buy the targeted plant, was executed on April 16, 2021, and calls for a long-form agreement to be signed within 30 days. Additionally, a long-form engineering and technical services agreement, with the option to acquire the engineering firm, Roberge Industries Inc., will be included in the final agreement.

St-Georges will design the battery recycling plant to be modular and preassembled to reduce construction and installation costs, timelines, and other challenges. The approach is to have a universal battery recycling plant that can use the procedures for process, safety, and maintenance anywhere in the world, including maintenance management systems with a technology allowing real-time auditing and the generation of tradeable carbon credits as well as machine learning management systems allowing real-time optimization of the process as well as the output based on market needs.

Read More: https://agoracom.com/ir/St-GeorgesEco-Mining/forums/discussion/topics/759273-st-georges-secures-future-ev-batteries-recycling-plant-engineering-expertise/messages/2312527#message